Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

NCT00865579 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

964

Enrollment

INDUSTRY

Sponsor class

Stopped study terminated early due to change in Sponsorship

Conditions

Parkinson's Disease

Interventions

DRUG: Safinamide

Sponsor

Newron Pharmaceuticals SPA